Coagulation Tests and Their Clinical Significance
Coagulation testing lets you localize a hemostatic defect to a specific pathway and translate laboratory patterns into diagnoses. PT interrogates the extrinsic and common pathways; PTT interrogates the intrinsic and common pathways; thrombin time isolates the final fibrinogen-to-fibrin conversion; and D-dimer reflects fibrinolysis. Reading these tests together — plus the mixing study — is the key to distinguishing factor deficiencies, anticoagulant effects, inhibitors, and consumptive states like DIC.
PT (Prothrombin Time)
PT tests the extrinsic and common pathways, assessing factors VII, X, V, II, and I. It is prolonged by warfarin, vitamin K deficiency, liver disease, and DIC. Its central clinical use is monitoring warfarin therapy via the INR. An isolated prolonged PT points to factor VII deficiency, early warfarin effect, or early liver disease — because VII (extrinsic) is affected before the common pathway. Remember that warfarin, vitamin K deficiency, and liver disease impair the vitamin K–dependent factors (II, VII, IX, X), and because factor VII has the shortest half-life, the PT is the sensitive early marker.
PTT (Partial Thromboplastin Time)
PTT tests the intrinsic and common pathways, covering factors XII, XI, IX, VIII, X, V, II, and I. It is prolonged by heparin, hemophilia A (VIII), hemophilia B (IX), and lupus anticoagulant. Von Willebrand disease prolongs the PTT only when the factor VIII level is significantly reduced (as in severe/type 3 disease), because vWF normally protects and stabilizes factor VIII; in most mild/type 1 vWD the PTT is normal, and the disease is instead detected by abnormal platelet-function/bleeding studies and vWF assays. Clinically PTT is used to monitor heparin and to screen for hemophilia. An isolated prolonged PTT should trigger a mixing study: it corrects with normal plasma in factor deficiency (e.g., hemophilia), but does NOT correct with an inhibitor such as lupus anticoagulant or a factor VIII inhibitor. Heparin also behaves like an inhibitor and fails to correct on a 1:1 mix — it is distinguished from a true antibody inhibitor by a markedly prolonged thrombin time with a normal reptilase time.
Thrombin Time
Thrombin time isolates the final common step: the conversion of fibrinogen to fibrin. It is prolonged by heparin, fibrinogen deficiency (hypo-/dysfibrinogenemia), and DIC. Its high-yield uses are detecting heparin contamination and evaluating fibrinogen disorders. Because it bypasses the upstream cascade, a prolonged thrombin time with an otherwise confusing PTT is a clean way to unmask a heparin effect — and the reptilase time (which is heparin-insensitive) stays normal in heparin contamination but is prolonged in true fibrinogen defects. Thrombin time is normal in antiphospholipid syndrome, helping exclude fibrinogen involvement when lupus anticoagulant is suspected.
D-dimer
D-dimer measures cross-linked fibrin degradation products and reflects fibrinolysis — it is reported as elevated, not prolonged. Its power lies in high sensitivity: a normal D-dimer helps rule out DVT and PE in low/intermediate pretest-probability patients. It is also elevated in DIC, where widespread microvascular thrombosis and secondary fibrinolysis generate large amounts of degradation products. Use it as a sensitive screening/exclusion tool rather than a specific confirmatory test.
Integrating the Pattern: PT + PTT + Fibrinogen
The combination of tests localizes the lesion. Prolonged PTT only: hemophilia A/B, heparin, lupus anticoagulant, or severe vWD with low factor VIII. Prolonged PT only: factor VII deficiency, early warfarin, or early liver disease. Both prolonged: a common-pathway problem, severe liver disease, warfarin, or DIC. In DIC, PT and PTT are prolonged, fibrinogen is low, and D-dimer is elevated — the low fibrinogen distinguishes DIC from TTP, where fibrinogen is normal. Always pair the coagulation panel with the clinical bleeding pattern: mucocutaneous bleeding and petechiae suggest a platelet/vascular (primary hemostasis) defect, whereas deep bleeding and hemarthrosis suggest a coagulation factor (secondary hemostasis) defect.
High-yield
- PT = extrinsic + common (VII, X, V, II, I); PTT = intrinsic + common (XII, XI, IX, VIII, X, V, II, I).
- PT/INR monitors warfarin; PTT monitors heparin.
- Isolated prolonged PT: factor VII, early warfarin, early liver disease.
- Isolated prolonged PTT: hemophilia A/B, heparin, lupus anticoagulant (severe vWD only when factor VIII is markedly low).
- vWD usually has a NORMAL PTT; it is picked up by abnormal platelet-function/bleeding studies and vWF assays.
- Both PT and PTT prolonged: common pathway, severe liver disease, DIC, warfarin.
- Mixing study corrects in factor deficiency; does NOT correct with an inhibitor (lupus anticoagulant, factor VIII inhibitor) — and heparin also fails to correct.
- Heparin vs true inhibitor: heparin gives a very prolonged thrombin time with a NORMAL reptilase time.
- Lupus anticoagulant paradox: prolongs PTT in vitro but causes thrombosis in vivo; confirm with dRVVT.
- Thrombin time isolates fibrinogen→fibrin and unmasks heparin contamination.
- D-dimer is highly sensitive to rule out DVT/PE and is elevated in DIC.
- DIC: prolonged PT/PTT, LOW fibrinogen, elevated D-dimer, both bleeding and thrombosis.
- Low fibrinogen distinguishes DIC from TTP (fibrinogen normal in TTP).
Pitfalls
- Saying D-dimer is 'prolonged' — it is elevated (a level), not a clotting time.
- Listing vWD as a routine cause of prolonged PTT — the PTT is usually normal and only prolongs when factor VIII is significantly reduced.
- Forgetting that heparin, like a true antibody inhibitor, does NOT fully correct on a 1:1 mixing study — distinguish it by a prolonged thrombin time with a normal reptilase time, not by a 'partial correction' pattern.
- Expecting a distinct 'partial correction' mixing pattern to signal heparin — mixing studies reliably separate factor deficiency (corrects) from inhibitor (does not correct); heparin is confirmed with thrombin/reptilase time.
- Assuming lupus anticoagulant causes bleeding — the prolonged PTT is an in vitro artifact; it actually causes thrombosis.
- Confusing DIC and TTP — check fibrinogen (low in DIC, normal in TTP).
- Attributing hemarthrosis to vWD or platelet disorders — deep joint bleeding is the hallmark of hemophilia (secondary hemostasis).
- Expecting an abnormal thrombin time in antiphospholipid syndrome — it is normal there.
- Ordering thrombophilia testing after a first provoked VTE, where the result won't change management.
Clinical pearls
- A normal D-dimer helps exclude DVT/PE because of its high sensitivity, not its specificity.
- Thrombin time is the quickest way to detect heparin contamination of a sample; a normal reptilase time confirms heparin as the culprit.
- Mucocutaneous bleeding/petechiae = primary hemostasis; deep bleeding/hemarthrosis = secondary hemostasis.
- In DIC, treat the underlying cause first; support with FFP or cryoprecipitate for low fibrinogen and bleeding.
- dRVVT confirms lupus anticoagulant when a prolonged PTT fails to correct with mixing.
Frequently asked
A prolonged PTT does not correct with a 1:1 mixing study — what does that mean?
Failure to correct indicates an inhibitor rather than a factor deficiency. In a patient with thrombosis (especially SLE with stroke), think lupus anticoagulant and confirm with the dilute Russell viper venom time (dRVVT); a factor VIII inhibitor is the other classic non-correcting antibody. Remember heparin contamination also fails to correct — distinguish it with a prolonged thrombin time and normal reptilase time.
How do I distinguish DIC from TTP on labs?
Both can have thrombocytopenia, but DIC prolongs PT and PTT with a LOW fibrinogen and elevated D-dimer, reflecting consumption. In TTP, fibrinogen is normal. Low fibrinogen is the key discriminator pointing to DIC.
Why is PT used for warfarin and PTT for heparin?
PT (via INR) is sensitive to the vitamin K–dependent factors of the extrinsic/common pathway that warfarin depletes, making it ideal for warfarin monitoring. PTT reflects the intrinsic/common pathway affected by heparin, so it is used for unfractionated heparin monitoring.
A patient has an unexpectedly prolonged PTT that does not correct on mixing — how do I know it is heparin rather than an antibody inhibitor?
Both heparin and antibody inhibitors fail to correct on a 1:1 mix, so the mixing study alone won't separate them. Order a thrombin time and reptilase time: heparin produces a markedly prolonged thrombin time with a normal reptilase time, and it can be neutralized by protamine or a heparin-absorbing reagent. This is the standard way to unmask sample or in vivo heparin.
A boy has recurrent hemarthroses, isolated prolonged PTT, and an affected maternal uncle — what is the test pattern telling you?
Deep joint bleeding plus isolated prolonged PTT and X-linked inheritance point to hemophilia. Because factor VIII deficiency (hemophilia A) is more common than factor IX deficiency (hemophilia B), it is the most likely diagnosis; the mixing study corrects, and a factor VIII assay confirms it.
Why can von Willebrand disease have a normal PTT?
vWF's role in coagulation testing is to carry and stabilize factor VIII. In mild/type 1 vWD the factor VIII level stays high enough to keep the PTT normal, so vWD is detected instead by abnormal platelet-function/bleeding studies and low vWF activity. The PTT prolongs only when factor VIII is significantly reduced, as in severe/type 3 disease.
What does an elevated D-dimer actually tell me?
It signals fibrinolysis with breakdown of cross-linked fibrin. It is highly sensitive but not specific, so a normal value helps rule out DVT/PE in appropriate patients, while an elevated value supports conditions such as DIC but is not confirmatory on its own.
When would the thrombin time be prolonged?
Thrombin time isolates fibrinogen-to-fibrin conversion and is prolonged by heparin, fibrinogen deficiency (hypo-/dysfibrinogenemia), and DIC. It is especially useful for detecting heparin contamination — where the reptilase time remains normal — and for evaluating fibrinogen disorders, and it is normal in antiphospholipid syndrome.
What does an isolated prolonged PT suggest?
It points to a defect in the extrinsic pathway or an early common-pathway insult: factor VII deficiency, early warfarin effect, or early liver disease, since VII has the shortest half-life and is affected first before the PTT also prolongs.
Turn this into reasoning you can use on exam day — practice Coagulation Tests and Their Clinical Significance on branching cases where your decisions shape the patient.